Rosetta Genomics Pink Sheet Forward View - Relative Strength Index
| ROSGQ Stock | USD 0.0002 0.00 0.00% |
Rosetta Pink Sheet outlook is based on your current time horizon.
As of today the relative strength index (rsi) of Rosetta Genomics' share price is below 20 indicating that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Rosetta Genomics hype-based prediction, you can estimate the value of Rosetta Genomics from the perspective of Rosetta Genomics response to recently generated media hype and the effects of current headlines on its competitors.
Rosetta Genomics after-hype prediction price | USD 1.23E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Rosetta |
Rosetta Genomics Additional Predictive Modules
Most predictive techniques to examine Rosetta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rosetta using various technical indicators. When you analyze Rosetta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Rosetta Genomics Volatility | Backtest Rosetta Genomics | Information Ratio |
Rosetta Genomics Trading Date Momentum
| On February 07 2026 Rosetta Genomics was traded for 0.0002 at the closing time. The highest daily price throughout the period was 0.0002 and the lowest price was 0.0002 . There was no trading activity during the period 0.0. Lack of trading volume on 02/07/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
| Compare Rosetta Genomics to competition |
Other Forecasting Options for Rosetta Genomics
For every potential investor in Rosetta, whether a beginner or expert, Rosetta Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rosetta Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rosetta. Basic forecasting techniques help filter out the noise by identifying Rosetta Genomics' price trends.Rosetta Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rosetta Genomics pink sheet to make a market-neutral strategy. Peer analysis of Rosetta Genomics could also be used in its relative valuation, which is a method of valuing Rosetta Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rosetta Genomics Market Strength Events
Market strength indicators help investors to evaluate how Rosetta Genomics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rosetta Genomics shares will generate the highest return on investment. By undertsting and applying Rosetta Genomics pink sheet market strength indicators, traders can identify Rosetta Genomics entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 |
Rosetta Genomics Risk Indicators
The analysis of Rosetta Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rosetta Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rosetta pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.98 | |||
| Standard Deviation | 12.31 | |||
| Variance | 151.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Rosetta Genomics
The number of cover stories for Rosetta Genomics depends on current market conditions and Rosetta Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rosetta Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rosetta Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Rosetta Pink Sheet Analysis
When running Rosetta Genomics' price analysis, check to measure Rosetta Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rosetta Genomics is operating at the current time. Most of Rosetta Genomics' value examination focuses on studying past and present price action to predict the probability of Rosetta Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rosetta Genomics' price. Additionally, you may evaluate how the addition of Rosetta Genomics to your portfolios can decrease your overall portfolio volatility.